EMD-23190

Single-particle
3.16 Å
EMD-23190 Deposition: 22/12/2020
Map released: 03/02/2021
Last modified: 29/05/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-23190

The full AAV7 capsid

EMD-23190

Single-particle
3.16 Å
EMD-23190 Deposition: 22/12/2020
Map released: 03/02/2021
Last modified: 29/05/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Adeno-associated virus - 7
Sample: Adeno-associated virus - 7
Fitted models: 7l5u (Avg. Q-score: 0.546)

Deposition Authors: Mietzsch M , Agbandje-McKenna M
Completion of the AAV Structural Atlas: Serotype Capsid Structures Reveals Clade-Specific Features.
PUBMED: 33450892
DOI: doi:10.3390/v13010101
ISSN: 1999-4915
Abstract:
The capsid structures of most Adeno-associated virus (AAV) serotypes, already assigned to an antigenic clade, have been previously determined. This study reports the remaining capsid structures of AAV7, AAV11, AAV12, and AAV13 determined by cryo-electron microscopy and three-dimensional image reconstruction to 2.96, 2.86, 2.54, and 2.76 Å resolution, respectively. These structures complete the structural atlas of the AAV serotype capsids. AAV7 represents the first clade D capsid structure; AAV11 and AAV12 are of a currently unassigned clade that would include AAV4; and AAV13 represents the first AAV2-AAV3 hybrid clade C capsid structure. These newly determined capsid structures all exhibit the AAV capsid features including 5-fold channels, 3-fold protrusions, 2-fold depressions, and a nucleotide binding pocket with an ordered nucleotide in genome-containing capsids. However, these structures have viral proteins that display clade-specific loop conformations. This structural characterization completes our three-dimensional library of the current AAV serotypes to provide an atlas of surface loop configurations compatible with capsid assembly and amenable for future vector engineering efforts. Derived vectors could improve gene delivery success with respect to specific tissue targeting, transduction efficiency, antigenicity or receptor retargeting.